1. Home
  2. BGT vs CYRX Comparison

BGT vs CYRX Comparison

Compare BGT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGT
  • CYRX
  • Stock Information
  • Founded
  • BGT 2004
  • CYRX 1999
  • Country
  • BGT United States
  • CYRX United States
  • Employees
  • BGT N/A
  • CYRX N/A
  • Industry
  • BGT Trusts Except Educational Religious and Charitable
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGT Finance
  • CYRX Health Care
  • Exchange
  • BGT Nasdaq
  • CYRX Nasdaq
  • Market Cap
  • BGT 322.6M
  • CYRX 365.5M
  • IPO Year
  • BGT N/A
  • CYRX N/A
  • Fundamental
  • Price
  • BGT $12.55
  • CYRX $7.49
  • Analyst Decision
  • BGT
  • CYRX Strong Buy
  • Analyst Count
  • BGT 0
  • CYRX 9
  • Target Price
  • BGT N/A
  • CYRX $10.67
  • AVG Volume (30 Days)
  • BGT 107.2K
  • CYRX 554.2K
  • Earning Date
  • BGT 01-01-0001
  • CYRX 08-05-2025
  • Dividend Yield
  • BGT 10.77%
  • CYRX N/A
  • EPS Growth
  • BGT N/A
  • CYRX N/A
  • EPS
  • BGT N/A
  • CYRX N/A
  • Revenue
  • BGT N/A
  • CYRX $232,134,000.00
  • Revenue This Year
  • BGT N/A
  • CYRX N/A
  • Revenue Next Year
  • BGT N/A
  • CYRX $9.63
  • P/E Ratio
  • BGT N/A
  • CYRX N/A
  • Revenue Growth
  • BGT N/A
  • CYRX 11.75
  • 52 Week Low
  • BGT $10.89
  • CYRX $4.58
  • 52 Week High
  • BGT $13.42
  • CYRX $9.78
  • Technical
  • Relative Strength Index (RSI)
  • BGT 55.61
  • CYRX 58.50
  • Support Level
  • BGT $12.44
  • CYRX $7.20
  • Resistance Level
  • BGT $12.76
  • CYRX $7.70
  • Average True Range (ATR)
  • BGT 0.12
  • CYRX 0.44
  • MACD
  • BGT 0.01
  • CYRX 0.02
  • Stochastic Oscillator
  • BGT 62.50
  • CYRX 73.89

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: